Skip to main content
×
×
Home

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis

  • Thomas A. Pollak (a1) and Belinda R. Lennox (a2)
Summary

It is time that all patients with acute-onset psychosis are screened for autoimmune encephalitis, that lumbar puncture becomes a routine psychiatric investigation and that immunotherapy is available in indicated cases. We call for a culture change in the management of psychosis by psychiatry.

Declaration of interest

None.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Correspondence: Belinda R. Lennox, DM, FRCPsych, Department of Psychiatry, Warneford Hospital, Warneford Lane Headington, Oxford OX3 7JX, UK. Email: belinda.lennox@psych.ox.ac.uk
Footnotes
Hide All

See pp. xx–xx, this issue.

Footnotes
References
Hide All
1Dalmau, J, Tuzun, E, Wu, HY, Masjuan, J, Rossi, JE, Voloschin, A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61(1): 2536.
2Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7(12): 1091–8.
3Titulaer, MJ, McCracken, L, Gabilondo, I, Armangue, T, Glaser, C, Iizuka, T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12(2): 157–65.
4Kayser, MS, Titulaer, MJ, Gresa-Arribas, N, Dalmau, J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 2013; 70(9): 1133–9.
5Yoshimura, B, Takaki, M. Anti-NMDA receptor antibody positivity and presentations without seizure, involuntary movement, hypoventilation, or tumor: a systematic review of the literature. J Neuropsychiatry Clin Neurosci 2017; 29(3): 267–74.
6Pearlman, DM, Najjar, S. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophr Res 2014; 157(1–3): 249–58.
7Scott, JG, Gillis, D, Ryan, AE, Hargovan, H, Gundarpi, N, McKeon, G, et al. The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJPsych Open 2018; 4(2): 6974.
8Graus, F, Titulaer, MJ, Balu, R, Benseler, S, Bien, CG, Cellucci, T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15(4): 391404.
9Lang, B, Makuch, M, Moloney, T, Dettmann, I, Mindorf, S, Probst, C, et al. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 2017; 88(4): 353–61.
10Oviedo-Salcedo, T, de Witte, L, Kumpfel, T, Kahn, RS, Falkai, P, Eichhorn, P, et al. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders. Br J Psychiatry 2018; 212(5): 318–20.
11Endres, D, Perlov, E, Baumgartner, A, Hottenrott, T, Dersch, R, Stich, O, et al. Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients. Front Hum Neurosci 2015; 9: 476.
12Bechter, K, Reiber, H, Herzog, S, Fuchs, D, Tumani, H, Maxeiner, HG. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res 2010; 44(5): 321–30.
13Kranaster, L, Koethe, D, Hoyer, C, Meyer-Lindenberg, A, Leweke, FM. Cerebrospinal fluid diagnostics in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 2011; 261(7): 529–30.
14Orlovska, S, Köhler-Forsberg, O, Brix, S, Nordentoft, M, Kondziella, D, Krogh, J, et al. Systematic review and meta-analysis of cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders. Neurol Psychiatry Brain Res 2018; 29: 17–8.
15Khandanpour, N, Hoggard, N, Connolly, DJ. The role of MRI and CT of the brain in first episodes of psychosis. Clin Radiol 2013; 68(3): 245–50.
16Albon, E, Tsourapas, A, Frew, E, Davenport, C, Oyebode, F, Bayliss, S, et al. Structural neuroimaging in psychosis: a systematic review and economic evaluation. Health Technol Assess 2008; 12(18): iiiiv, ix-163.
17Falkenberg, I, Benetti, S, Raffin, M, Wuyts, P, Pettersson-Yeo, W, Dazzan, P, et al. Clinical utility of magnetic resonance imaging in first-episode psychosis. Br J Psychiatry 2017; 211(4): 231–7.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Open
  • ISSN: -
  • EISSN: 2056-4724
  • URL: /core/journals/bjpsych-open
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 612
Total number of PDF views: 432 *
Loading metrics...

Abstract views

Total abstract views: 975 *
Loading metrics...

* Views captured on Cambridge Core between 16th July 2018 - 19th August 2018. This data will be updated every 24 hours.

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis

  • Thomas A. Pollak (a1) and Belinda R. Lennox (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *